$27.08
0.86% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US03763A2078
Symbol
ASTH

Astrana Health Stock price

$27.08
-2.48 8.39% 1M
-13.96 34.02% 6M
-4.45 14.11% YTD
-11.98 30.67% 1Y
-9.03 25.01% 3Y
+9.76 56.35% 5Y
+20.58 316.62% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.23 0.86%
ISIN
US03763A2078
Symbol
ASTH
Sector

Key metrics

Market capitalization $1.35b
Enterprise Value $1.31b
P/E (TTM) P/E ratio 37.34
EV/FCF (TTM) EV/FCF 25.23
EV/Sales (TTM) EV/Sales 0.58
P/S ratio (TTM) P/S ratio 0.60
P/B ratio (TTM) P/B ratio 1.78
Revenue growth (TTM) Revenue growth 54.81%
Revenue (TTM) Revenue $2.25b
EBIT (operating result TTM) EBIT $79.79m
Free Cash Flow (TTM) Free Cash Flow $52.12m
Cash position $260.91m
EPS (TTM) EPS $0.73
P/E forward 23.78
P/S forward 0.52
EV/Sales forward 0.50
Short interest 6.22%
Show more

Is Astrana Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Astrana Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Astrana Health forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Astrana Health forecast:

Buy
75%
Hold
25%

Financial data from Astrana Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,251 2,251
55% 55%
100%
- Direct Costs 2,011 2,011
63% 63%
89%
239 239
7% 7%
11%
- Selling and Administrative Expenses 130 130
16% 16%
6%
- Research and Development Expense - -
-
-
109 109
1% 1%
5%
- Depreciation and Amortization 30 30
60% 60%
1%
EBIT (Operating Income) EBIT 80 80
14% 14%
4%
Net Profit 35 35
44% 44%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Astrana Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Astrana Health Stock News

Neutral
Seeking Alpha
11 days ago
Astrana Health, Inc. (NASDAQ:ASTH ) Q1 2025 Earnings Conference Call May 8, 2025 5:30 PM ET Company Participants Brandon Sim - President & Chief Executive Officer Chan Basho - Chief Operating & Financial Officer. Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jack Slevin - Jefferies Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Brooks O'Neil - Lake S...
Neutral
PRNewsWire
12 days ago
Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m.
Neutral
PRNewsWire
27 days ago
ALHAMBRA, Calif. , April 24, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO, and Chan Basho, CFO ...
More Astrana Health News

Company Profile

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam on November 1, 1985 and is headquartered in Alhambra, CA.

Head office United States
CEO Brandon Sim
Employees 1,900
Founded 1985
Website www.astranahealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today